CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Ipsen bolsters rare disease pipeline in €700m Memo takeover

Positive
AI Analysis

Summary

Ipsen acquired Memo for €700 million to bolster its rare disease pipeline, marking the company's second major acquisition in one week following its Kartos buyout on June 29.

Importance:7/10
Sentiment:
0.60
rare_diseaseacquisitionpipeline_expansionM&A
Related Companies

Read the original article

Published by Pharmaceutical Technology on July 2, 2026 12:19 PM

Read Original